NFKB1 and Alzheimer disease: The primary regulatory mechanism involves H3K18 lactylation modulating the senescence-associated secretory phenotype (SASP), specifically via the NF-κB pathway's induction of IL-6 and IL-8, thereby intensifying neuroinflammation, brain aging, and the progression of Alzheimer's disease [21].